Methyl 6-chloro-1H-indazole-3-carboxylate

Catalog No. :
ACMBJN396
CAS No. :
717134-47-9
Molecular Formula :
C9H7ClN2O2
Molecular Weight :
210.62

IUPAC Name:methyl 6-chloro-1H-indazole-3-carboxylate

Methyl 6-chloro-1H-indazole-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$116.00Login to see priceIn stockIn stock
25g97%$522.00Login to see priceIn stockIn stock
100g97%$1668.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 6-chloro-1H-indazole-3-carboxylate
IUPAC Namemethyl 6-chloro-1H-indazole-3-carboxylate
MDL No.MFCD07371602
Molecular FormulaC9H7ClN2O2
Molecular Weight210.62
SMILESO=C(C1=NNC2=C1C=CC(Cl)=C2)OC
InChI KeyALYJEMREXVWPMM-UHFFFAOYSA-N
SynonymMFCD07371602 | 1H-Indazole-3-carboxylic acid, 6-chloro-, methyl ester | DS-13176 | ALYJEMREXVWPMM-UHFFFAOYSA-N | 6-CHLORO-1H-INDAZOLE-3-CARBOXYLIC ACID METHYL ESTER | DTXSID90635047 | SCHEMBL4791992 | AKOS016002873 | FT-0740320 | METHYL 6-CHLORO-1H-INDAZO
CAS No.717134-47-9
PubChem CID23577858

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACMBJN396 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMBJN396 route product structure diagram
    ACMBJN396717134-47-9 In Stock
Inquiry

2. ACMBJN396 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACEUSW146 route compound structure diagram
    ACEUSW146129295-31-4 In Stock
  4. Then
  5. ACMBJN396 route product structure diagram
    ACMBJN396717134-47-9 In Stock
Inquiry

Comments (0)